位置:首页 > 蛋白库 > CFR_STAAU
CFR_STAAU
ID   CFR_STAAU               Reviewed;         349 AA.
AC   A5HBL2; Q3MQ55;
DT   02-SEP-2008, integrated into UniProtKB/Swiss-Prot.
DT   12-JUN-2007, sequence version 1.
DT   03-AUG-2022, entry version 72.
DE   RecName: Full=Ribosomal RNA large subunit methyltransferase Cfr {ECO:0000255|HAMAP-Rule:MF_01873};
DE            EC=2.1.1.224 {ECO:0000255|HAMAP-Rule:MF_01873, ECO:0000269|PubMed:21415317};
DE   AltName: Full=23S rRNA (adenine(2503)-C(8))-methyltransferase {ECO:0000255|HAMAP-Rule:MF_01873};
DE   AltName: Full=23S rRNA m8A2503 methyltransferase {ECO:0000255|HAMAP-Rule:MF_01873};
GN   Name=cfr {ECO:0000255|HAMAP-Rule:MF_01873};
OS   Staphylococcus aureus.
OG   Plasmid pSCFS3.
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcaceae;
OC   Staphylococcus.
OX   NCBI_TaxID=1280;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=11; PLASMID=pSCFS3;
RX   PubMed=16569824; DOI=10.1128/aac.50.4.1156-1163.2006;
RA   Kehrenberg C., Schwarz S.;
RT   "Distribution of florfenicol resistance genes fexA and cfr among
RT   chloramphenicol-resistant Staphylococcus isolates.";
RL   Antimicrob. Agents Chemother. 50:1156-1163(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROBABLE FUNCTION, AND ANTIBIOTIC
RP   RESISTANCE.
RC   STRAIN=CM05;
RX   PubMed=17555436; DOI=10.1111/j.1365-2958.2007.05744.x;
RA   Toh S.M., Xiong L., Arias C.A., Villegas M.V., Lolans K., Quinn J.,
RA   Mankin A.S.;
RT   "Acquisition of a natural resistance gene renders a clinical strain of
RT   methicillin-resistant Staphylococcus aureus resistant to the synthetic
RT   antibiotic linezolid.";
RL   Mol. Microbiol. 64:1506-1514(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION IN ANTIBIOTIC RESISTANCE.
RC   STRAIN=004-737X;
RX   PubMed=18391032; DOI=10.1128/aac.00231-08;
RA   Mendes R.E., Deshpande L.M., Castanheira M., DiPersio J., Saubolle M.A.,
RA   Jones R.N.;
RT   "First report of cfr-mediated resistance to linezolid in human
RT   staphylococcal clinical isolates recovered in the United States.";
RL   Antimicrob. Agents Chemother. 52:2244-2246(2008).
RN   [4]
RP   FUNCTION IN ANTIBIOTIC RESISTANCE, AND METHYLTRANSFERASE ACTIVITY.
RC   STRAIN=405/2002;
RX   PubMed=16091044; DOI=10.1111/j.1365-2958.2005.04754.x;
RA   Kehrenberg C., Schwarz S., Jacobsen L., Hansen L.H., Vester B.;
RT   "A new mechanism for chloramphenicol, florfenicol and clindamycin
RT   resistance: methylation of 23S ribosomal RNA at A2503.";
RL   Mol. Microbiol. 57:1064-1073(2005).
RN   [5]
RP   COFACTOR.
RX   PubMed=21916495; DOI=10.1021/ja207327v;
RA   Grove T.L., Radle M.I., Krebs C., Booker S.J.;
RT   "Cfr and RlmN contain a single [4Fe-4S] cluster, which directs two distinct
RT   reactivities for S-adenosylmethionine: methyl transfer by SN2 displacement
RT   and radical generation.";
RL   J. Am. Chem. Soc. 133:19586-19589(2011).
RN   [6]
RP   FUNCTION AS A 23S RRNA A2503 METHYLTRANSFERASE, CATALYTIC ACTIVITY, AND
RP   REACTION MECHANISM.
RX   PubMed=21415317; DOI=10.1126/science.1200877;
RA   Grove T.L., Benner J.S., Radle M.I., Ahlum J.H., Landgraf B.J., Krebs C.,
RA   Booker S.J.;
RT   "A radically different mechanism for S-adenosylmethionine-dependent
RT   methyltransferases.";
RL   Science 332:604-607(2011).
CC   -!- FUNCTION: Specifically methylates position 8 of adenine 2503 in 23S
CC       rRNA. Confers resistance to some classes of antibiotics, such as
CC       chloramphenicol, florfenicol, clindamycin and linezolid.
CC       {ECO:0000255|HAMAP-Rule:MF_01873, ECO:0000269|PubMed:16091044,
CC       ECO:0000269|PubMed:18391032, ECO:0000269|PubMed:21415317}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=adenosine(2503) in 23S rRNA + 2 reduced [2Fe-2S]-[ferredoxin]
CC         + 2 S-adenosyl-L-methionine = 5'-deoxyadenosine + 8-
CC         methyladenosine(2503) in 23S rRNA + L-methionine + 2 oxidized [2Fe-
CC         2S]-[ferredoxin] + S-adenosyl-L-homocysteine; Xref=Rhea:RHEA:42632,
CC         Rhea:RHEA-COMP:10000, Rhea:RHEA-COMP:10001, Rhea:RHEA-COMP:10152,
CC         Rhea:RHEA-COMP:10153, ChEBI:CHEBI:17319, ChEBI:CHEBI:33737,
CC         ChEBI:CHEBI:33738, ChEBI:CHEBI:57844, ChEBI:CHEBI:57856,
CC         ChEBI:CHEBI:59789, ChEBI:CHEBI:74411, ChEBI:CHEBI:74543;
CC         EC=2.1.1.224; Evidence={ECO:0000255|HAMAP-Rule:MF_01873,
CC         ECO:0000269|PubMed:21415317};
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01873,
CC         ECO:0000269|PubMed:21916495};
CC       Note=Binds 1 [4Fe-4S] cluster. The cluster is coordinated with 3
CC       cysteines and an exchangeable S-adenosyl-L-methionine.
CC       {ECO:0000255|HAMAP-Rule:MF_01873, ECO:0000269|PubMed:21916495};
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_01873}.
CC   -!- MISCELLANEOUS: Reaction proceeds by a ping-pong mechanism involving
CC       intermediate methylation of a conserved cysteine residue. In details,
CC       the methyl group from one SAM molecule is initially transferred to Cys-
CC       338 in a typical SN2 displacement. Then a 5'-dA radical formed from a
CC       second molecule of SAM abstracts a hydrogen from the methyl group of
CC       mCys-338, and the resulting Cys-appended methyl radical attacks the
CC       substrate adenine ring. Methyl transfer to C8 thus results in a
CC       covalent adduct between the substrate and Cys-338, which is resolved by
CC       formation of a disulfide bond between Cys-338 and a second conserved
CC       Cys residue (Cys-105) (Probable). {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the radical SAM superfamily. RlmN family. Cfr
CC       subfamily. {ECO:0000255|HAMAP-Rule:MF_01873}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AM086211; CAJ30491.1; -; Genomic_DNA.
DR   EMBL; EF450709; ABQ00063.1; -; Genomic_DNA.
DR   EMBL; KC206006; ACC77590.1; -; Genomic_DNA.
DR   RefSeq; WP_001010505.1; NZ_VRRS01000001.1.
DR   RefSeq; WP_032491462.1; NG_047632.1.
DR   RefSeq; YP_007878372.1; NC_021076.1.
DR   RefSeq; YP_007988851.1; NC_021230.1.
DR   AlphaFoldDB; A5HBL2; -.
DR   SMR; A5HBL2; -.
DR   GeneID; 64233978; -.
DR   BRENDA; 2.1.1.224; 3352.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0016433; F:rRNA (adenine) methyltransferase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0019843; F:rRNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW.
DR   GO; GO:0070475; P:rRNA base methylation; IEA:UniProtKB-UniRule.
DR   Gene3D; 3.20.20.70; -; 1.
DR   HAMAP; MF_01873; 23SrRNA_methyltr_Cfr; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR040072; Methyltransferase_A.
DR   InterPro; IPR022881; rRNA_lsu_MeTfrase_Cfr.
DR   InterPro; IPR004383; rRNA_lsu_MTrfase_RlmN/Cfr.
DR   InterPro; IPR007197; rSAM.
DR   PANTHER; PTHR30544; PTHR30544; 1.
DR   Pfam; PF04055; Radical_SAM; 1.
DR   PIRSF; PIRSF006004; CHP00048; 1.
DR   SFLD; SFLDF00275; adenosine_C2_methyltransferase; 1.
DR   SFLD; SFLDF00296; adenosine_C8_methyltransferase; 1.
DR   SFLD; SFLDS00029; Radical_SAM; 2.
DR   TIGRFAMs; TIGR04432; rSAM_Cfr; 1.
DR   PROSITE; PS51918; RADICAL_SAM; 1.
PE   1: Evidence at protein level;
KW   4Fe-4S; Antibiotic resistance; Cytoplasm; Disulfide bond; Iron;
KW   Iron-sulfur; Metal-binding; Methyltransferase; Plasmid; rRNA processing;
KW   S-adenosyl-L-methionine; Transferase.
FT   CHAIN           1..349
FT                   /note="Ribosomal RNA large subunit methyltransferase Cfr"
FT                   /id="PRO_0000350426"
FT   DOMAIN          98..333
FT                   /note="Radical SAM core"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01266"
FT   ACT_SITE        91
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01873"
FT   ACT_SITE        338
FT                   /note="S-methylcysteine intermediate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01873"
FT   BINDING         112
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /ligand_note="4Fe-4S-S-AdoMet"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01873"
FT   BINDING         116
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /ligand_note="4Fe-4S-S-AdoMet"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01873"
FT   BINDING         119
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /ligand_note="4Fe-4S-S-AdoMet"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01873"
FT   BINDING         158..159
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01873"
FT   BINDING         189
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01873"
FT   BINDING         212..214
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01873"
FT   BINDING         293
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01873"
FT   DISULFID        105..338
FT                   /note="(transient)"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01873"
FT   CONFLICT        254
FT                   /note="A -> D (in Ref. 1; CAJ30491)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   349 AA;  39862 MW;  53C5F48D61BE94CD CRC64;
     MNFNNKTKYG KIQEFLRSNN EPDYRIKQIT NAIFKQRISR FEDMKVLPKL LREDLINNFG
     ETVLNIKLLA EQNSEQVTKV LFEVSKNERV ETVNMKYKAG WESFCISSQC GCNFGCKFCA
     TGDIGLKKNL TVDEITDQVL YFHLLGHQID SISFMGMGEA LANRQVFDAL DSFTDPNLFA
     LSPRRLSIST IGIIPSIKKI TQEYPQVNLT FSLHSPYSEE RSKLMPINDR YPIDEVMNIL
     DEHIRLTSRK VYIAYIMLPG VNDSLEHANE VVSLLKSRYK SGKLYHVNLI RYNPTISAPE
     MYGEANEGQV EAFYKVLKSA GIHVTIRSQF GIDIDAACGQ LYGNYQNSQ
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024